臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"huang j w"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 301-325 / 943 (共38頁)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-07-20T03:15:44Z	Risk factors for high dialysate glucose use in pd patients-a retrospective 5-year cohort study	Wu H.-Y.; Hung K.-Y.; Hu F.-C.; Chen Y.-M.; TZONG-SHINN CHU; Huang J.-W.; Wu K.-D.; Tsai T.-J.
臺大學術典藏	2021-07-20T03:15:43Z	Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients	Lin Y.-F.; Chen Y.-M.; Hung K.-Y.; TZONG-SHINN CHU; Kan W.-C.; Huang C.-Y.; Lin S.-L.; Kao T.-W.; Huang J.-W.; Chiang W.-C.; Yen C.-J.; Tsai T.-J.; Wu K.-D.; Wu M.-S.
臺大學術典藏	2021-07-20T03:15:43Z	Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients	Kao T.-W.; Huang J.-W.; Hung K.-Y.; Chang Y.-Y.; Chen P.-C.; Yen C.-J.; Chen Y.-M.; TZONG-SHINN CHU; Wu M.-S.; Tsai T.-J.; Wu K.-D.; Wang J.-D.
臺大學術典藏	2021-07-20T03:15:42Z	Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting	Huang T.-M.; Wu V.-C.; Young G.-H.; Lin Y.-F.; Shiao C.-C.; Wu P.-C.; Li W.-Y.; Yu H.-Y.; Hu F.-C.; Lin J.-W.; Chen Y.-S.; Lin Y.-H.; Wang S.-S.; Hsu R.-B.; Chang F.-C.; Chou N.-K.; TZONG-SHINN CHU; Yeh Y.-C.; Tsai P.-R.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; Ko W.-J.; Wu K.-D.
臺大學術典藏	2021-07-20T03:15:39Z	Safety issues of long-term glucose load in patients on peritoneal dialysis-A 7-year cohort study	Wu H.-Y.; Hung K.-Y.; Huang T.-M.; Hu F.-C.; Peng Y.-S.; Huang J.-W.; Lin S.-L.; Chen Y.-M.; TZONG-SHINN CHU; Tsai T.-J.; Wu K.-D.
臺大學術典藏	2021-07-20T03:15:38Z	U-Curve Association between Timing of Renal Replacement Therapy Initiation and In-Hospital Mortality in Postoperative Acute Kidney Injury	Shiao C.-C.; Ko W.-J.; Wu V.-C.; Huang T.-M.; Lai C.-F.; Lin Y.-F.; Chao C.-T.; TZONG-SHINN CHU; Tsai H.-B.; Wu P.-C.; Young G.-H.; Kao T.-W.; Huang J.-W.; Chen Y.-M.; Lin S.-L.; Wu M.-S.; Tsai P.-R.; Wu K.-D.; Wang M.-J.
臺大學術典藏	2021-07-20T03:15:35Z	Multidisciplinary care program for advanced chronic kidney disease: Reduces renal replacement and medical costs	Chen P.M.; Lai T.S.; Chen P.Y.; Lai C.F.; Yang S.Y.; Wu V.; Chiang C.K.; Kao T.W.; Huang J.W.; Chiang W.C.; Lin S.L.; Hung K.Y.; Chen Y.M.; TZONG-SHINN CHU; Wu M.S.; Wu K.D.; Tsai T.J.
臺大學術典藏	2021-07-20T03:15:33Z	Functional assessment of chronic illness therapy-the fatigue scale exhibits stronger associations with clinical parameters in chronic dialysis patients compared to other fatigue-assessing instruments	Chao C.-T.; Huang J.-W.; Chiang C.-K.; Yen C.-J.; Hung Y.-C.; Hsu S.-H.; Shih C.-Y.; Lai C.-F.; Chan D.-C.D.; Hung K.-Y.; TZONG-SHINN CHU; Huang S.-J.; COGENT (COhort of GEriatric Nephrology in NTUH) study group
臺大學術典藏	2021-07-20T03:15:30Z	Comparative effectiveness of angiotensinconverting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study	Wu H.-Y.; Peng C.-L.; Chen P.-C.; Chiang C.-K.; Chang C.-J.; Huang J.-W.; Peng Y.-S.; Tu Y.-K.; TZONG-SHINN CHU; Hung K.-Y.; Chien K.-L.
臺大學術典藏	2021-07-20T03:15:22Z	Cerebral microbleeds in autosomal dominant polycystic kidney disease	Tsai L.-K.; Chen P.-L.; Tsai H.-H.; Chen Y.-F.; Wu P.-C.; Jeng J.-S.; Huang J.-W.; TZONG-SHINN CHU; Kao J.T.-W.
臺大學術典藏	2021-07-06T08:49:45Z	Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel	Huang J.-W.; Kuo C.-H.; Kuo H.-C.; Shih J.-Y.; Tsai T.-W.; LIN-CHAU CHANG
臺大學術典藏	2021-07-06T08:49:44Z	Differences in Fatty Acid Oxidation between Nab-Paclitaxel- And Solvent-Based Paclitaxel-Treated A549 Cells Based on Metabolomics	Huang J.-W.; Kuo C.-H.; Kuo H.-C.; Shih J.-Y.; Tsai T.-W.; LIN-CHAU CHANG
臺大學術典藏	2021-07-06T02:03:52Z	Cerebral microbleeds in autosomal dominant polycystic kidney disease	Tsai L.-K.; PEI-LUNG CHEN; Tsai H.-H.; Chen Y.-F.; Wu P.-C.; Jeng J.-S.; Huang J.-W.; Chu T.-S.; Kao J.T.-W.
臺大學術典藏	2021-07-03T03:34:40Z	Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf	Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; Cheng A.-L.; PEI-JER CHEN; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:35Z	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:30Z	Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity	Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:29Z	Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists	Su J.-C.; Chen K.-F.; Chen W.-L.; Liu C.-Y.; Huang J.-W.; Tai W.-T.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-03T03:34:13Z	SC-60, a dimer-based sorafenib derivative, shows a better anti-hepatocellular carcinoma effect than sorafenib in a preclinical hepatocellular carcinoma model	Tai W.-T.; Shiau C.-W.; Li Y.-S.; Chen Y.-L.; Chu P.-Y.; Huang J.-W.; Hsu C.-Y.; Hsu Y.-C.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:34:12Z	Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma	Tai W.-T.; Shiau C.-W.; PEI-JER CHEN; Chu P.-Y.; Huang H.-P.; Liu C.-Y.; Huang J.-W.; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:49Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2011) 55(5) (1041–1048)(S0168827811001917)(10.1016/j.jhep.2011.01.047))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:47Z	Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))	Tai W.-T.; Cheng A.-L.; Shiau C.-W.; Huang H.-P.; Huang J.-W.; PEI-JER CHEN; Chen K.-F.
臺大學術典藏	2021-07-03T03:33:42Z	Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))	Chen K.-F.; Tai W.-T.; Hsu C.-Y.; Huang J.-W.; Liu C.-Y.; PEI-JER CHEN; Kim I.; Shiau C.-W.
臺大學術典藏	2021-07-01T03:16:59Z	Natural and non-natural antioxidative compounds: potential candidates for treatment of vascular calcification	Chao C.-T.;Yeh H.-Y.;Tsai Y.-T.;Chuang P.-H.;Yuan T.-H.;Huang J.-W.;Huei-Wen Chen; Chao C.-T.; Yeh H.-Y.; Tsai Y.-T.; Chuang P.-H.; Yuan T.-H.; Huang J.-W.; HUEI-WEN CHEN
臺大學術典藏	2021-07-01T03:16:58Z	Astaxanthin counteracts vascular calcification in vitro through an early up-regulation of SOD2 based on a transcriptomic approach	Chao C.-T.;Yeh H.-Y.;Tsai Y.-T.;Yuan T.-H.;Liao M.-T.;Huang J.-W.;Huei-Wen Chen; Chao C.-T.; Yeh H.-Y.; Tsai Y.-T.; Yuan T.-H.; Liao M.-T.; Huang J.-W.; HUEI-WEN CHEN
臺大學術典藏	2021-06-25T07:22:06Z	Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis	YU-FENG LIN; Huang J.-W.; Wu M.-S.; Chu T.-S.; Lin S.-L.; Chen Y.-M.; Tsai T.-J.; Wu K.-D.

顯示項目 301-325 / 943 (共38頁)
<< < 8 9 10 11 12 13 14 15 16 17 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 53252791 線上人數 : 655 教育部委託研究計畫計畫執行:國立臺灣大學圖書館